Lixte Biotechnology Holdings, Inc. Common Stock (LIXT)

Lixte Biotechnology Holdings, Inc. is a biotechnology company focused on the discovery and development of targeted therapies for cancers and neurological disorders. The company utilizes its proprietary drug discovery platform to identify small-molecule compounds aimed at specific disease targets, with an emphasis on developing novel treatments with potential for clinical application.

🚫 Lixte Biotechnology Holdings, Inc. Common Stock does not pay dividends

Company News

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
GlobeNewswire Inc. • 24/7 Market News • August 15, 2025

LIXTE Biotechnology is advancing its cancer therapy pipeline with LB-100, a protein phosphatase 2A inhibitor targeting ovarian clear cell carcinoma, soft tissue sarcoma, and metastatic colon cancer, with potential trial results expected in late 2025.

Gold Moves Higher; Velo3D Shares Plummet
Benzinga • Avi Kapoor • March 27, 2024

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74. The S&P 500 also rose, gaining, 0.36% to 5,222.18. Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1   Leading and Lagging Sectors   Utilities shares jumped by 2% on Wednesday. In trading on Wednesday, communication services shares fell by 0.5%.   Top Headline   Cintas Corporation (NASDAQ: CTAS) reported better-than-expected third-quarter financial results and raised FY24 guidance. Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company’s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from Benzinga Pro. Cintas increased FY24 annual revenue expectations from $9.48 billion-$9.56 billion to $9.57 billion-$9.60 billion (estimate: $9.56 billion). The firm raised EPS outlook from $14.35-$14.65 to $14.80-$15.00 (estimate: $14.60).   Equities Trading UP   Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares shot up 44% to $3.2571 after the company announced the publication of pre-clinical data on its lead clinical ...

How to Sustainably Invest in Penny Stocks 
PennyStocks • D. Marie • February 13, 2023

Here's some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.